| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/20/2006 | EP1218049B1 Apparatus for relieving headaches, rhinitis and other common ailments |
| 09/20/2006 | EP1200081B1 Use of escitalopram for the treatment of generalised anxiety disorder |
| 09/20/2006 | EP0929569B1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 09/20/2006 | EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives |
| 09/20/2006 | EP0889889B1 Piperazine and piperidine compounds |
| 09/20/2006 | EP0799037B1 Compositions for treating allergic rhinitis and other disorders comprising descarboethoxyloratadine |
| 09/20/2006 | EP0774004B1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 09/20/2006 | CN1835971A Improved secretion of neublastin |
| 09/20/2006 | CN1835956A Acylated and non-acylated imidazo [2,1-b]-1, 3, 4,-thiadiazole-2-sulfonamides, and uses thereof |
| 09/20/2006 | CN1835950A Imidazopyridine derivatives |
| 09/20/2006 | CN1835938A Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 09/20/2006 | CN1835936A Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 09/20/2006 | CN1835935A Stable polymorph of bifeprunox mesilate |
| 09/20/2006 | CN1835931A Tetrahydroquinazolines and dihydrocyclopentapyrimidines as CFR antagonists |
| 09/20/2006 | CN1835929A 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |
| 09/20/2006 | CN1835921A N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
| 09/20/2006 | CN1835754A Stable medical freeze dried preparation of tetraodotoxin |
| 09/20/2006 | CN1835753A Spiro tetrahydroquinazolines and dihydrocyclopentapyrimidines as CFR antagonists |
| 09/20/2006 | CN1835747A Use of 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 09/20/2006 | CN1833711A Medicine for treating apoplectic sequel and prepn. thereof |
| 09/20/2006 | CN1833710A Dispensing for treating trifacial neuralgia |
| 09/20/2006 | CN1833709A Honey capsule |
| 09/20/2006 | CN1833703A Medicine for treating peripheral nervous disease of diabets mellitus and prepn. method |
| 09/20/2006 | CN1833692A False portulaca oleracea extracts, its prepn. and usage |
| 09/20/2006 | CN1833672A Chinese medicinal honey bolus for treating apoplexia sequel and its mfg. method |
| 09/20/2006 | CN1833671A Paste for relieving mammary gland gall |
| 09/20/2006 | CN1833668A Medicinal compsns. having cooperative action |
| 09/20/2006 | CN1833663A Sustained release capsules of ginkgo leaf and prepn. method |
| 09/20/2006 | CN1833647A Clinical preparation of compounded tall gastrodia tuber |
| 09/20/2006 | CN1833633A Liposome able to transmit blood and brain screen, medicinal compsns. using hiposome as carrier and its prepn. method |
| 09/20/2006 | CN1276083C Altering gene expression with ssDNA produced in vivo |
| 09/20/2006 | CN1275977C O-aryl glucoside SGL T2 inhibitors |
| 09/20/2006 | CN1275967C Benzensulfonic acid indol-5-yl esters and antigonists of the 5-HT6 receptor |
| 09/20/2006 | CN1275964C 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation |
| 09/20/2006 | CN1275954C Hydroxamic acid derivatives |
| 09/20/2006 | CN1275951C Novel benzothiazine derivatives, their preparation and use |
| 09/20/2006 | CN1275945C Meptazinol ortho-propionyloxy-cis-benzyl acrylate and its salts and their production method |
| 09/20/2006 | CN1275917C Glucocorticoid receptor modulators |
| 09/20/2006 | CN1275635C Compound plaster of dahurian angelica root and its preparation method |
| 09/20/2006 | CN1275620C Medicine for treating senile dementia |
| 09/20/2006 | CN1275600C Vitamin-medicine composition and its use |
| 09/20/2006 | CN1275594C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 09/19/2006 | US7109354 Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 09/19/2006 | US7109351 Fused pyrrolecarboxamides; GABA brain receptor ligands |
| 09/19/2006 | US7109342 Antiinflammatory agents; antiallergens; autoimmune diseases |
| 09/19/2006 | US7109339 Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists |
| 09/19/2006 | US7109296 Used to identify modulators of the 5-HT3 serotonin receptor complex, and to reconstitute a more realistic physiological 5-HT3 receptor response in recombinant systems |
| 09/19/2006 | US7109246 Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug |
| 09/19/2006 | US7109234 Benzoxathiepine derivatives and their use as medicines |
| 09/19/2006 | US7109218 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/19/2006 | US7109215 Compounds possessing neuronal activity |
| 09/19/2006 | US7109214 neuropeptide alpha -calcitonin gene-related peptide antagonists; treatment of pain; headache; asthma; cardiovascular disorders; for reducing morphine tolerance |
| 09/19/2006 | US7109208 Rho kinase inhibitors having axon of the retinal ganglion cellal extension- and optic nerve cell regeneration- promoting action, particularly (R)-(+)-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)-4-(1-aminoethyl)benzamide |
| 09/19/2006 | US7109207 Used to treat metabolic disorders, eating disorders such as hyperphagia, and diabetes |
| 09/19/2006 | US7109205 Pyrimidine or 1,3,-triazine derivatives; endothelin receptor antagonists |
| 09/19/2006 | US7109203 for use in the treatment or prevention of diseases in which bradykinin B1 receptor activation plays a role |
| 09/19/2006 | US7109202 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 09/19/2006 | US7109201 5-HT1D receptor antagonist activity; antidepressants |
| 09/19/2006 | US7109199 5-(2,3-Difluorophenyl)-1H-pyrazolo(3,4-c)pyridazin-3-ylamine, e.g.; an enzyme inhibitor of GSK-3, a serine/threonine protein kinase; neuroprotectants in treatment of acute stroke, neurotraumatic injuries and diabetic conditions |
| 09/19/2006 | US7109194 3-heteroaryl-3, 5-dihydro-4-oxo-4H-pyridazino[4, 5-b]indole-1-carboxamide derivatives their preparations and therapeutic use |
| 09/19/2006 | US7109193 Tricyclic diazepines tocolytic oxytocin receptor antagonists |
| 09/19/2006 | US7109189 Mitochondrially targeted antioxidants |
| 09/19/2006 | US7109164 Administering compounds such as 3-[[3,5-dibromo-[4-hydroxy-3-(1-methylethyl)phenoxy]-phenyl]amino]-3-oxopropanoic acid for therapy of obesity, hypercolesterolemia atherosclerosis, depression, osteoporosis, hypothyroidism, goiter, glaucoma, cardiac arrhythmia, congestive heart failure, or a skin disorder |
| 09/19/2006 | US7109027 Aβ-Peptide screening assay |
| 09/19/2006 | US7108975 Atlastin |
| 09/19/2006 | US7108871 Isoflavones and saponins in defined ratios, menopause, cancer |
| 09/19/2006 | US7108868 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
| 09/19/2006 | US7108847 Delivery of muscle relaxants through an inhalation route |
| 09/19/2006 | CA2388830C Oral solution containing galanthamine and a sweetening agent |
| 09/19/2006 | CA2232195C Isoxazolidine derivatives |
| 09/14/2006 | WO2006096780A2 Sirtuin related therapeutics and diagnostics for neurodegenerative diseases |
| 09/14/2006 | WO2006096435A1 Pharmaceutical compositions for the treatment and/or prevention of depression |
| 09/14/2006 | WO2006096404A2 Treatment of amyotrophic lateral sclerosis with norethindrone and anal0gues |
| 09/14/2006 | WO2006096358A1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists |
| 09/14/2006 | WO2006095836A1 Antipruritic agent for pruritus caused by multiple sclerosis |
| 09/14/2006 | WO2006095674A1 Method for study, determination or evaluation |
| 09/14/2006 | WO2006095671A1 Novel salt of quinuclidine derivative |
| 09/14/2006 | WO2006095666A1 Pyrazolopyridine-4-yl pyridazinone derivative and addition salt thereof, and pde inhibitor comprising the derivative or salt as active ingredient |
| 09/14/2006 | WO2006095263A1 Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds |
| 09/14/2006 | WO2006095205A1 Heteroarylsulfonyl stilbenes as 5-ht2a antagonists |
| 09/14/2006 | WO2006095187A1 Benzoxazocines and their therapeutic use |
| 09/14/2006 | WO2006095173A2 Medical uses of 39-desmethoxyrapamycin and analogues thereof |
| 09/14/2006 | WO2006095074A1 Anti-smoking composition |
| 09/14/2006 | WO2006095014A1 2- (4-0x0-4h-quinaz0lin-3-yl) acetamides and their use as vasopressin v3 antagonists |
| 09/14/2006 | WO2006094948A1 Diaza-spiro-[4.4]-nonane derivatives as neurokinin (nk1) antagonists |
| 09/14/2006 | WO2006094934A1 Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists |
| 09/14/2006 | WO2006094843A1 Piperazine derivatives as glyt1 inhibitors |
| 09/14/2006 | WO2006094842A1 Acylated piperidihes as glycine transporter inhibitors |
| 09/14/2006 | WO2006094840A1 Compounds |
| 09/14/2006 | WO2006094811A2 Use of microtubule stabilizing compounds for the treatment of lesions of cns axons |
| 09/14/2006 | WO2006094764A1 Formulation for aviptadil |
| 09/14/2006 | WO2006094704A2 Natural ligand of g protein coupled receptor rcc356 and uses thereof |
| 09/14/2006 | WO2006094691A1 PYRAZINE -2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS |
| 09/14/2006 | WO2006094639A1 Pyridine-2-carboxamide derivatives as mglur5 antagonists |
| 09/14/2006 | WO2006086464A3 Dihydroquinazolinones as 5ht modulators |
| 09/14/2006 | WO2006066203A3 Small interfering rna (sirna) molecules for modulating superoxide dismutase (sod) |
| 09/14/2006 | WO2006040151A8 Subsituted hydroxyethylamine compounds for treating alzheimer’s disease |
| 09/14/2006 | WO2006034296A3 Amino-containing compounds which inhibit memapsin 2 beta-secretase activity and methods of use thereof |
| 09/14/2006 | WO2006033505A8 Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or cholic acid derivatives |
| 09/14/2006 | WO2006016707A3 Pyrazolone compounds for treating cerebrovascular disorders |